Alicia Romero-Lorca

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2026
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.

|Oct 29, 2025
Tumour SNPs Associated with Immune-Related Hepatitis in Patients with Melanoma Receiving Immune Checkpoint Inhibitors.

Jose María Rodríguez-Piñas, Alicia Romero-Lorca, Maria Gaibar

|Feb 11, 2023
HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.

Apolonia Novillo, María Gaibar, Alicia Romero-Lorca

|Apr 08, 2020
Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.

Maria Gaibar, Laura Beltrán, Alicia Romero-Lorca

|Jan 09, 2019
UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data.

Apolonia Novillo, María Gaibar, Alicia Romero-Lorca

Pageof 1

Frequent Collaborators

5 joint publications

Apolonia Novillo

5 joint publications

Ana Fernández-Santander

2 joint publications

Maria Gaibar

1 joint publications

J M Rodríguez-Piñas